Tao Sun

机构：Shihezi University, Beijing Institute of Technology, Wuhan University, Open Targets, Gene Therapy Laboratory, Gannan Medical University, Luoyang Normal University, Renmin Hospital of Wuhan University, Liaoning Cancer Hospital & Institute · ORCID：0000-0001-8062-3432

发表论文 345 篇 · 总被引 11831 次 · h-index 44

代表论文

• Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 109)
• Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA (2025 · Journal of Thoracic Oncology · 被引 13)
• Elevated nitric oxide during colitis restrains GM-CSF production in ILC3 cells via suppressing an AhR-Cyp4f13-NF-κB axis (2025 · Nature Communications · 被引 9)
• Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial (2025 · Cancer Cell · 被引 4)
• Digital technologies in psoriasis management: from precision diagnosis to therapeutic innovation and holistic care (2025 · Frontiers in Digital Health · 被引 4)
• ALG13 Deficiency and Epilepsy-Related Cognitive Impairment: Role of the DDIT4-Mediated PI3K/AKT/mTOR Pathway (2025 · Neurochemical Research · 被引 4)